Variants in the fat mass and obesity associated (FTO) gene are associated with obesity and C-reactive protein levels in Chinese Han populations Abstract Purpose: Various genetic variants of the fat mass and obesity associated gene (FTO) have been linked to obesity in populations of Europeans. Low-grade in ammation is a key feature of obesity, characterized by elevated plasma levels of C-reactive protein (CRP). In the present study, we have investigated whether the FTO-risk variant is associated with obesity and CRP in the Chinese population.
Obesity and higher body mass index (BMI) are known to be associated with hypertension and related disease risks [1, 2] . Obesity is a leading risk factor for multiple common diseases such as type 2 diabetes, heart diseaseand hypertension, and has a strong genetic component [3] although the underlying genetic causes are poorly understood [4] . Recent studies have revealed a strong association between common variants in the rst intron of FTO and obesity in children and adults [4] . FTO protein expression could be a key link between the central nervous system and systemic energy balance. e amino acid sequence of the FTO protein shows a high homology with the enzyme AlkB, which oxidatively demethylates DNA [5, 6] . Furthermore, recombinant FTO protein catalyzes demethylation of 3-methylthymine in single-stranded DNA [5] . FTO was found to be signi cantly up-regulated (41%) in the hypothalamus of rats a er 48 hours of food deprivation [7] . Increases in hypothalamic expression of FTO were associated with the regulation of food intake. Studies also found a strong negative correlation between the expression of FTO expression and the expression of orexigenic galanin-like peptide, which is mainly synthesized in the arcuate nucleus. ese results are consistent with the hypothesis that FTO could participate in the central control of energy homeostasis [7] . e FTO genetic code for2-oxoglutarate-dependent nucleic acid demethylase is widely expressed in human tissues [5] . Researchers have observed high FTO expression in the brain, particularly in the hypothalamic nuclei governing energy balance. Many peripheral tissues, including the eye and skeletal muscle, have displayed equally high levels of FTO mRNA [7] . C-reactive protein (CRP) an acute phase protein and marker of chronic, low grade in ammation, is a reliable predictor of cardiovascular disease [8] . Low grade in ammation is a key feature of obesity and is characterized by elevated plasma levels of CRP. CRP is made by the liver in response to in ammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNFα) [8] . Adipose tissue is a major source of these in ammatory cytokines [9] . erefore, we investigated whether the FTO-risk variant is associated not only with obesity but also with C-reactive protein levels in the Chinese population.
Methods
We recruited 1799 individuals aged 50-70 years (896 men and 903 women), who are all of Han nationality from the Hubei province of China, and who are unrelated to outpatients or volunteers at the Physical Examination Center at the ZhongNan Hospital of Wuhan University. Of these subjects, 39 were excluded because of genotyping failure. is study had been reviewed and approved by HuBei Ethics Committee. e study subjects had been given informed consent to participate in the study by letters of advice.
Obese subjects (560 individuals) were de ned as having BMI≥28 kg/m 2 , according to Chinese criteria [10] . Waist circumferences, by gender, (male: WC>90cm; female: WC >80cm) de ned as central obesity [10] . e control subjects (1200 individuals exhibited normal clinical and biochemical characteristics .
Additional selection criteria included the absence of (1) renal dysfunction (serum creatinine >180 mmol/L), (2) liver disease, (3) severe physical or mental disease, (for example, malignancy, terminal cancer or dementia), (4) pregnancy (history and serum β-hCG >2500 mIU/ml) and (5) substance abuse, including alcohol.
Height and weight were measured with participants dressed in lightweight clothing without shoes. BMI was calculated as the weight in kilograms divided by the square of height in meters. Body fat percentage was assessed using dual energy X-ray absorptiometry. Waist circumference (in centimeters) was measured midway between the lowest rib and the iliac crest to the nearest 0.1 cm a er inhalation and exhalation. Hip circumference was measured over the widest part of the gluteal region and the waist-to-hip ratio (WHR) was calculated. Plasma CRP levels were assayed using a highly sensitive turbidimetric immunoassay kit with an analytical sensitivity of 0.1 mg/l. e within and between assay coe cients of variance were <2% in standardized quality control samples and the inter-and intraassay variability was <1% in the overall assay. Blood total cholesterol, triglycerides and LDL-C were also measured. Arterial blood pressure was measured using a mercury sphygmomanometer on the right arm with the subjects in a sitting position a er a 5 minute rest.
Each subject donated 5 ml of blood sample for genomic DNA extraction. Genotyping was carried out as previously described [11] . Polymerase chain reaction (PCR) was used to amplify a 155-bp fragment which contains the FTO rs9939609 polymorphism. e reaction was performed on an automated DNA thermal cycler (Beijing Institute of Technology, China) with the primers of FTO rs9939609 polymorphism (FP:5'-AAGAGATGATCTCAAATCTACTTTATGAGAT Sun et al. e Association of FTO with obesity and CRP A-3' and RP: 5'-TTAGAGTAACAGAGACTATCCAAGT GCATCAT-3' , annealing temperature 54 C, 30 cycles) [12] .
e PCR product was puri ed by ExoSAP-IT kit (Amersham Biosciences, UKand Gel Extraction puri cation.
e FTO rs9939609 polymorphism genotyped using sequences retrieval by ABI BigDye 3.1 kit through the ABI 3730XL sequencing equipment (SinoGenoMax, China).
e sequencing results were analyzed by CHROMAS 2.01.
Statistical analysis was performed using SPSS 11.5 for Windows. Genotype and allele frequencies were compared with the Hardy-Weinberg equilibrium model and then analyzed by χ 2 testing using contingency tables respectively. e observed gene frequencies of the cases and controls were used to calculate the genotype frequency. Allelic and genotypic associations of the FTO rs9939609 polymorphism variant found signi cant were evaluated by computing odds ratios and 95% CIs. All data were presented as means±SD. e clinical and biochemical characteristics between these genotypes were compared by oneway ANOVA. e association between FTO polymorphism and plasma CRP levels was evaluated using correlation coecient, standardized regression coe cients (beta), partial correlation coe cients (partial Rs) and overall coe cient of determination (R2). e association between fat measurements and plasma CRP was assessed using linear regression analysis. CRP levels were logarithmically transformed. P < 0.05 was considered signi cant. All statistical analyses were sequentially adjusted for sex, age, BMI, WHR, hypertension and diabetes status, and use of NSAIDs, through four ANCOVA models (see recommendation below).
Results
All the genotype and allele frequencies of FTO rs9939609 polymorphism are in agreement with the Hardy-Weinberg equilibrium (P>0.05). Genotype distribution was signi cantly di erent between obese patients and controls. e A allele frequency was signi cantly higher in obese patients than controls (48.4% 39.8%, P<0.05). e AA frequencies were 22.1% (patients) 17.1% (controls). e per-A allele increases of odds ratio for obesity was 1.42 (95%CI 1.23-1.64). e genotypic odds ratio for obesity was 1. olesterol; TG: total triglyceride de ; HDL, high-density lipoe FTO rs9939609 polymorphism A allele was found to be associated with CRP levels in men and women (Table 4) : in age adjusted analyses, the associations were statistically signicant in both men (P = 0.002) and in women (P =0.01). When further adjusted for BMI, body fat and WHR, the association was slightly attenuated in women and much more obviously attenuated in men (Table 4) . Further adjustment for age, BMI, waist-to-hip ratio, prevalent diseases (hypertension and diabetes), use of NSAID, statins and blood pressure lowering medication and smoking status, did not appreciably change the association (Table 4 ). e association between adiposity and logCRP was also evaluated. Waist circumference and BMI were signi cantly correlated with CRP levels in both male and female subjects (Table  5) ; however, body fat was signi cantly related to CRP only in female subjects.
Discussion
Obesity is reaching epidemic proportions and has become a serious health problem as it contributes to the increasing burden of , heart disease, hypertension and dyslipidemia [12] . Although numerous gene variants have been found to be associated with obesity or obesity-related phenotypes, only a few have been consistently replicated [13] [14] [15] [16] . Recently, genome-wide associations, followed by large-scale replication studies, have shown studies on FTO to be a major success in the eld of obesity genetics [17, 18] . Its role as a gene predisposing individuals to higher BMI, obesity [18] [19] [20] [21] [22] [23] [24] [25] , fat mass [17, 18, 22, 24, 26] , and risk [17, 22, [27] [28] [29] [30] [31] has been con rmed in many populations.
In this study, we con rmed the association of FTO with obesity in Chinese Han population. Our analysis demonstrated signi cant association of FTO with BMI and obesity in Chinese population (P<0.05). e FTO gene function is still unknown but is thought to encode a non-heme (FeII)-dioxygenase with a potential role in adaptation to hypoxia, lipolysis or DNA methylation [5, 6] . e FTO protein is expressed in almost all tissues and is localized in the nucleus [5] . e molecular mechanisms involved in the pathogenesis of obesity as well as the role of FTO in other complex disorders are unknown.
Obesity is characterized by chronic subclinical in ammation, which plays an essential role in the development of atherosclerosis [32] . Prospective, epidemiological studies have shown high CRP to be a major contributor to the risk of , independent of measures of body adiposity [33] . ere exists variability in CRP levels, which presumably follows specifc patterns of several genes, such as polymorphisms, a triallelic SNP rs3091244 (C→T C→A) of the CRP gene. Wessel et al. showed that genetic variants in the catecholaminergic/β-adrenergic pathway might contribute to the predictive value of CRP levels [34] .
As expected, strong observational associations were found between FTO and C-reactive protein levels. is suggest that the FTO variant not only increases the size of the adipose tissue stores, but may also enhance the in ammatory state of adipose tissue stores and may increase systemic infammation, independently of the degree of adiposity. Recent protein alignment and functional analyses have shown that FTO contains an active 2-oxoglutarate-dependent oxygenase domain that catalyses the demethylation of DNA [5] but details on the functional role of the FTO SNP in the pathophysiology of human obesity remain unknown. It has been postulated that the mechanism may involve leptin resistance, caused by the binding of the molecule to CRP [35] : the FTO SNP could provoke a positive feedback on top of its underlying functional impact on BMI. Certainly, this needs addition study.
e present study has some limitations. e single time point design of this study is a limitation of our research. e CRP levels were measured only once in this study; however, we and others showed that intra-individual CRP levels are reasonably stable when compared at di erent points in time, even when measurements are made several years apart [3637] . Another limitation to this study was the small sample size. Hence, our ndings cannot be generalized to the greater Chinese community. It is possible that the association observed was attributable to other genetic variant(s) in strong linkage disequilibrium with the FTO polymorphism. comparisons between en AA and AT AA and
In conclusion, we found that FTO is a major risk factor for obesity in the Chinese Han population, and its e ects play an important role in fat mass deposition and obesity prevalence.
e explanation for this may be that its protein is a key link between the central nervous system and energy balance. At the same time, a signi cant association was found between FTO and C-reactive protein levels; however, this association may not be valid for the entire Chinese population. e progress of obesity or diabetes is determined not only by genetic factors, but by factors such as environment. ese factors each exert a di erent impact at each step of disease development, complicating analysis. Whether a single gene can be associated with obesity or in what way is a complicated question.
us, proof-of-concept and prospective studies are needed to further investigate the physiology and the impact of the FTO polymorphisms and associated gene products. From a population perspective, only the combined e ects of the most potent genetic variants should be then considered. 
